Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact

In the realm of infectious diseases, the management of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) poses a signi!cant challenge to healthcare providers. Dalbavancin, a long-acting lipoglycopeptide antibiotic, has emerged as a promising option in the treatment of ABSSSIs in adults. This article aimed at exploring the prescriptive appropriateness of dalbavancin by adopting an integrated approach which considered clinical pro!le, patient- and health system-related factors, and environmental impact.